Synthesis and characterization of new and potent α-lipoic acid derivatives

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 5, 2004, Pages 1183-1190

  Gruzman, Arie ^a   Hidmi, Adel ^a   Katzhendler, Jehoshua ^a   Haj Yehie, Abdalla ^a   Sasson, Shlomo ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antihyperglycemic drugs; Glucose transport; Lipoic acid, Prodrug

Indexed keywords

5 [1,2] DITHIOLAN 3 YLPENTANOIC ACID 3 (5 [1,2] DITHIOLAN 3 YLPENTANOYLAMINO)PROPYLAMIDE; 5 [1,2] DITHIOLAN 3 YLPENTANOIC ACID 3 (5 [1,2] DITHIOLAN 3 YLPENTANOYLOXY)PROPYL ESTER; THIOCTIC ACID; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; RAT; SKELETAL MUSCLE;

ANIMALIA;

EID: 1342343121     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.11.025     Document Type: Article

References (31)

1. Randle P.J. Diabetes Metab. Rev. 14:1998;263.
2. Evans J.L., Goldfine I.D. Diabetes Technol. Ther. 2:2000;401.
3. Biewenga G.P., Haenen G.R., Bast A.A. Gen. Pharmacol. 29:1997;315.
4. Packer L., Witt E.H., Tritschler H. J. Free Rad. Biol. Med. 19:1995;227.
5. Han D., Handleman G., Marcocci L., Sen C.K., Roy S., Kobuchi H., Tritschler H.J., Flohe L., Packer L. Bio Factors. 6:1997;321.
6. Betteridge D. J. Metabolism. 49:2000;3.
7. Baynes J.W., Thorpe S.R. Diabetes. 48:1999;1.
8. Paolissio G., Giugliano D. Diabetologia. 39:1996;357.
9. Wollheim C. Diabetologia. 43:2000;265.
10. Biewenga G., Haenen G.R., Bast A. Drug Metab. Rev. 29:1997;1025.
11. Jacob S., Henriksen E.J., Schiemann A.L., Simon I., Clancy D.F., Tritschler H.J., Jung W.I., Aufustine H.J., Dietze G. J. Arzeneimittel- Forschund. 45:1995;872.
12. Haaguard N., Haaguard E. Biochim. Biophys. Acta. 222:1970;583.
13. Estrada D.E., Ewart H.S., Tsakiridis T., Volchuk A., Ramlal T., Tritshler H.J., Klip A. Diabetes. 45:1996;1798.
14. Ramrath S., Tritshler H.J., Eckel J. Horm. Metab. Res. 31:1999;632.
15. Breithaupt-Grogler K., Neibch G., Schneider E., Erb K., Hermann R., Blume H.H., Schug B.S., Belz G.C. Eur. J. Pharm. Sci. 8:1999;57.
16. Marangon K., Devaraj S., Tirosh O., Packer L., Jialal I. Free. Rad. Biol. Med. 27:1999;1114.
17. Nefkens G., Tesser G. J. Am. Chem. Soc. 83:1961;1263.
18. Anderson G.W., Zimmerman J.E., Callahan F.M. J. Am. Chem. Soc. 86:1964;1839.
19. Spirada P.K. Chem. Phys. Lipids. 48:2000;157.
20. Walker P., Ramla T., Donovan J., Doering T., Sandra A., Clip A., Pessin E. J. Biol. Chem. 264:1989;6587.
21. Teishert J., Preiss R. Int. J. Clin. Pharm. Ther. Toxicol. 30:1992;511.
22. Junge W., Krisch K. Crit. Rev. Toxicol. 3:1975;371.
23. Mark L., Kayden H., Steele J., Cooper J., Berlin I., Rovenstein E., Brodie B. J. Pharmacol. Exp. Ther. 102:1951;5.
24. Heymann,E. In The Organic Chemistry of Drug Design And Drug Actions; Academic Press; New-York, 1980, Vol. 2, p. 291.
25. Anderson G.W., Zimmerman J.E., Callahan F.M. J. Am. Chem. Soc. 85:1963;3039.
26. Luo Y., Prestwich G.D. Biocojugate Chem. 12:2001;1085.
27. Zalipsky, S. US Patent 5,122,614, 1992.
28. Kozlovsky N., Rudich A., Potashnik R., Bashan N. Free Rad. Biol. Med. 23:1997;859.
29. Kaiser N., Sasson S., Feener E., Boukobza-Vardi N., Higashi S., Moller D.E., Davidheiser S., Przybylski R.J., King G.L. Diabetes. 42:1993;80.
30. Bradford M. Anal. Biochem. 72:1972;248.
31. Haluzic M., Nedvedkova J. Physiol. Res. 49(Suppl 1):2000;S37.